🔎 Trials Near Me

Utama › Kanser Pankreas › California › Sacramento

Kajian klinikal Kanser Pankreas di Sacramento, CA

12 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Sacramento (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Mengambil pesertaFasa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05372614

Distance-Based Exercise to Preserve Function and Prevent Disability

Mengambil peserta
  • Kaiser Permanente-South Sacramento, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Mengambil pesertaFasa 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Mengambil pesertaKajian pemerhatian
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 50 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT04239573

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Mengambil pesertaFasa 1/2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04172532

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Mengambil pesertaFasa 3
  • Sutter Medical Center Sacramento, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • UC Davis, Sacramento
Umur 18 hingga 90 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT04970056

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Mengambil pesertaFasa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT07189195

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Mengambil pesertaFasa 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT06040541

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Mengambil pesertaFasa 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • Sutter Davis Hospital, Davis · 14 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06998940

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Mengambil pesertaFasa 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Ogo 2025 · NCT04429542

Kajian Kanser Pankreas di bandar lain

Kajian lain di Sacramento

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.